Class C beta-lactamase from Escherichia coli in complex with Tazobactam

Center for Structural Genomics of Infectious Diseases (CSGID)

Center for Structural Genomics of Infectious Diseases
NIAID, National Institute of Allergy and Infectious Diseases

class C beta-lactamase, Tazobactam, structural genomic, CSGID, Structural Genomics, Center for Structural Genomics of Infectious Diseases, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR complex

binding site for Di-peptide TBE B 501 and SER B 91

binding site for Di-peptide TBE C 402 and SER C 91

binding site for Di-peptide TBE D 501 and SER D 91